Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information communication from Roche Products (Ireland) Ltd. and Novartis Ireland Ltd. on new warning about the risks of hypogammaglobulinaemia and bronchiectasis with Cellcept (mycophenolate mofetil) and Myfortic (mycophenolic acid).
Important Safety Information - Cellcept (mycophenolate mofetil) and Myfortic (mycophenolic acid)